PDL BioPharma, Inc. Deferred Revenue Recognized
PDL BioPharma, Inc. reported Deferred Revenue Recognized of -$1.74 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2021-03-29
- PDL BioPharma, Inc. contract with customer, liability, revenue recognized for fiscal 2020 was -$1.74M.
- PDL BioPharma, Inc. contract with customer, liability, revenue recognized for fiscal 2018 was -$9.75M.
| Period end | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|
| 2020-12-31 | -$1.74M 10-K · filed 2021-03-29 | ||
| 2020-09-30 | $1.74M 10-Q · filed 2020-11-13 | ||
| 2020-06-30 | $1.51M 10-Q · filed 2020-08-07 | ||
| 2019-12-31 | -$7.95M 8-K · filed 2020-06-29 | ||
| 2018-12-31 | -$9.75M 10-K · filed 2019-03-15 | ||
| 2018-06-30 | -$9.40M 10-Q · filed 2018-08-09 |